Navigation Links
PricewaterhouseCoopers to Present First International Market Scorecard on Medical Technology Innovation at the 2010 International Medical Device Industry Compliance Congress
Date:3/10/2010

NEW YORK, March 10 /PRNewswire/ -- PricewaterhouseCoopers announced today that it will present findings from an independent study of international market conditions for medical device innovation at the 2010 International Medical Device Industry Compliance Congress.  The conference, which is one of the largest international gatherings of medical device companies in the world, is being held in Berlin, Germany, May 3-5, 2010.

Doug Mowen, managing director and leader of PricewaterhouseCoopers' Medical Device practice, will present "Device Innovation Scorecard: Comparing Global Innovation Factors in Selected Countries Relevant to Medical Device Companies" during the closing keynote address on May 5.  The presentation will include top line findings of PricewaterhouseCoopers' independent analysis of key factors that create access to or barriers for medical device innovation in nine markets:  Brazil, China, France, Germany, Israel, India, Japan, United Kingdom and the United States.  

The presentation will include an Innovation Scorecard of the characteristics in each of the markets as well as a comparison across multiple markets.  The Innovation Scorecard is based on rigorous, proprietary methodology, developed by PricewaterhouseCoopers, using approximately 100 key metrics to determine a score for each of the following four areas:    

  1. The over-all regulatory environment, including the regulatory approval process and reimbursement methodologies.
  2. Access, including patient access to care delivery, the availability of adequate healthcare infrastructure and medical staff, technology infrastructure and penetration of Internet and mobile technologies.
  3. Demographics, including key population health measures, disease and risk factors as well as innovation workforce demographics such as the availability of scientists, engineers.
  4. Market factors, including the availability of public and private investment, R&D expenditures, the level of collaboration between companies and academia, and the historical track record of medical technology in the market.

PricewaterhouseCoopers conducted the independent study to help its clients, patient advocacy groups, regulators, ministers of health and other government and health industry leaders to better understand the ability of patients to access innovative medical technology in their own territories, the opportunities for economic development as well as product development, manufacturing and commercial market opportunities for medical device companies seeking to expand both domestically and internationally.

The 2010 International Medical Device Industry Compliance Congress is co-sponsored by 14 global medical technology associations.  The annual meeting brings together medical device industry executives, compliance and legal officers from both small and large medical technology manufacturers from across the globe.

About PricewaterhouseCoopers Pharmaceutical and Life Sciences Industry Group

PricewaterhouseCoopers Pharmaceutical and Life Sciences Industry Group (www.pwc.com/medtech) provides clients with audit, tax and advisory services. The firm has extensive experience in delivering industry-tailored solutions on a wide range of strategic, financial and operational issues. The Pharmaceutical and Life Sciences Industry Group is part of PricewaterhouseCoopers' larger initiative for the health-related industries that brings together expertise and allows collaboration across all sectors in the health continuum.

About PricewaterhouseCoopers

PricewaterhouseCoopers (www.pwc.com) provides industry-focused assurance, tax and advisory services to build public trust and enhance value for its clients and their stakeholders.  More than 163,000 people in 151 countries across our network share their thinking, experience and solutions to develop fresh perspectives and practical advice.

"PricewaterhouseCoopers" refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.

© 2010 PricewaterhouseCoopers LLP. All rights reserved

SOURCE PricewaterhouseCoopers

Back to top

RELATED LINKS
http://www.pwc.com

'/>"/>

SOURCE PricewaterhouseCoopers
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. $232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers
2. Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
10. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
11. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Corporation ("Unilife" or "Company") (NASDAQ: UNIS ; ASX: UNS), ... its financial results for the second quarter of fiscal 2016 (three ... Financial Results for the Second Quarter of ... Revenue for the second quarter of fiscal 2016 was $4.5 ... Cash receipts from customers for the second quarter of fiscal 2016 ...
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... February 9, 2016 QGEN ... collaboration with 10x Genomics to develop and promote ... and bioinformatics. --> QGEN ; Frankfurt ... 10x Genomics to develop and promote comprehensive solutions ... --> QIAGEN N.V. (NASDAQ: QGEN ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading ... the fourth quarter and full year ended December 31, 2015 on Monday, February 29, ... webcast for the investment community following the release at 4:30 PM ET. Investors interested ...
(Date:2/10/2016)... Carefree, AZ (PRWEB) , ... February 10, 2016 , ... ... coach in new book , Pioneering book "Better with Age: The Ultimate Guide to ... neuroplasticity can improve memory. The book’s publication date is March 16, 2016. ...
(Date:2/10/2016)... MA (PRWEB) , ... February 10, 2016 , ... ... their revolutionary, biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns combine ... provide a solution that ensures the integrity of biological samples while operating at ...
(Date:2/10/2016)... ... February 10, 2016 , ... The recreational use of marijuana has been ... still face a lot of restrictions as to where they can smoke pot. ... use” and that cannabis “may not be consumed openly or publicly.” , Given the ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Face and Body Specialists are delighted to welcome a new addition to their ... Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
Breaking Medicine News(10 mins):